Media Thread, page-11257

Congrats @davybabyk ,

This is another wonderful post around the potential of our B-Cell tech. As you know, I am also a great fan of both
HER-Vaxx and PD1-Vaxx. It seems the new and improved HER-Vaxx is going almost unnoticed, which is a shame.

Davy, I must 'highlight' one of your statements, which could be a knock out ,but is also flying under the radar. You state ...

"Any potential purchaser of Her-vaxx is probably also interested in PD1-vaxx, because a combo of Her-vaxx plus PD1-vaxx
should be even better than a Her-vaxx plus Keytruda combination. Two B cell drugs with superb safety/tolerability,
working together, should be much better than Her-vaxx in combo with Keytruda - which can have quite nasty side effects."

This combo could be a knockout ... safer, definitely; more efficacy, probably. So, equals = winner. Excellent point Davy.
So much safer than Keytruda.

Some wonderful New Year reading coming through the IMU threads at the moment. So, besides Davy's generous sharing
I would also like to acknowledge @Taureanbull @LHI 14 @Rainman56 @Footmax and, on other threads ...
@Watmighthavben and @Jov88

There are many others, which is wonderful to see. Well done folks, and have a safe and prosperous New Year.